AL IMTIAZ INVESTMENT GROUP COMPANY - K.S.C. (PUBLIC) Date: 12/10/2023
Ref: 116/BK/CAD/2023
Boursa Kuwait Company
Kuwait
Subject: Supplementary Disclosure of Material Information
In reference to the above subject, and the requirements of the fourth chapter of Module Ten (Disclosure and Transparency) of the Executive Bylaws of Law No 7 of 2010 regarding the establishment of the Capital Markets Authority and regulating securities activities and their amendments, please find enclosed the Supplementary Disclosure Form of Material Information.
Sincerely,
Saad Sami Al-Bader
Acting Chief Executive Officer
Date
Name of the listed Company
Disclosure Title
Date of Previous
Disclosure
Developments that Occurred to Disclosure
The Financial Effect of the Occurring Developments (if any)
Supplementary Disclosure form
12/10/2023
ALIMTIAZ INVESTMENT GROUP COMPANY
Supplementary disclosure from Al-Imtiaz Investment Group Company regarding one of its subsidiaries.
27/10/2022
Al-Ritaj Holding Company (a subsidiary of Al Imtiaz) reported that it rejected the offer received to acquire its entire stake in one of its subsidiary companies in the Arab Republic of Egypt (Delta Pharmaceutical Industries Company), due to the current decline in the value of the Egyptian pound against major currencies, which resulted in a decrease in the value of the offer's equivalent in Kuwaiti dinars. Al-Ritaj Holding Company will continue to monitor economic conditions in the Arab Republic of Egypt in order to source suitable exit opportunities for its investment in Delta Pharmaceutical Industries Company.
No financial impact
Saad Sami Al-Bader
Acting Chief Executive Officer
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Alimtiaz Investment Group Co. KSCP published this content on 12 October 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 October 2023 11:20:28 UTC.
